✦ LIBER ✦

35: Low Dose Valganciclovir for CMV Prophylaxis after Lung Transplantation

✍ Scribed by H.S. Khurana; G. Chaux; A. Kole; J. Falk; S. Simsir; W. Cheng; R.M. Kass; J. Khurana; G. Soohoo

Book ID: 116520343
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 61 KB
Volume: 27
Category: Article
ISSN: 1557-3117
DOI: 10.1016/j.healun.2007.11.039

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low-Dose Valganciclovir for Cytomegalovi

Low-Dose Valganciclovir for Cytomegalovirus Prophylaxis in Heart Transplant Recipients

✍ Julian, K.G.; Shattahi, E.; Burg, J.E.; Boehmer, J.P. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 199 KB

Valganciclovir for the prophylaxis of ea

Valganciclovir for the prophylaxis of early cytomegalovirus (CMV) infection after allogeneic stem cell transplantation

✍ C. Bachier; P. Shaughnessy; D. Wall; M. Grimley; G. Carrum; C. Freytes; N. Calla 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Following Universal Prophylaxis with Int

Following Universal Prophylaxis with Intravenous Ganciclovir and Cytomegalovirus Immune Globulin, Valganciclovir is Safe and Effective for Prevention of CMV Infection Following Lung Transplantation

✍ Martin R. Zamora; Mark R. Nicolls; Tony N. Hodges; Jane Marquesen; Todd Astor; T 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

350: Clinical efficacy of long-term low

350: Clinical efficacy of long-term low dose acyclovir for VZV infection prophylaxis after allogeneic peripheral blood stem cell transplantation

✍ D.H. Kim; H.A. Messner; V. Gupta; J. Kuruvilla; Y.S. Chae; S.K. Sohn; J.H. Lipto 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Low-dose intramuscular hepatitis B immun

Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation

✍ G Ferretti; M Merli; S Ginanni Corradini; V Callejon; P Tanzilli; A Masini; S Fe 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Ultra Low-Dose IL-2 for GVHD Prophylaxis

Ultra Low-Dose IL-2 for GVHD Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation Mediates Expansion of Regulatory T Cells without Diminishing Antiviral and Antileukemic Activity

✍ Kennedy-Nasser, A. A.; Ku, S.; Castillo-Caro, P.; Hazrat, Y.; Wu, M.-F.; Liu, H. 📂 Article 📅 2014 🏛 American Association for Cancer Research 🌐 English ⚖ 976 KB